Bruce McClenathan MD, FACP, FAAAAI

Education

College: Jacksonville State University, Jacksonville, AL 1992-1995
Medical School: University of South Alabama, Mobile AL 1995-1999
Residency: Tripler Army Medical Center, Hawaii 1999-2002
Fellowship: Walter Reed Army Medical Center, Washington, DC 2003-2005
Command & General Staff College-ILE, Ft. Lee, VA Sep-Dec 2009
Graduate Stanford Faculty Development Course Feb 2012

Biography

Bruce McClenathan, MD is the regional medical director of the Defense Health Agency-Immunization Healthcare Branch at Fort Bragg, NC. Dr. McClenathan is a board-certified Internist and Allergist and Immunologist with a special interest in vaccines and the evaluation and management of patients with vaccine adverse events. He holds the Academic rank of Assistant Professor of Medicine and Pediatrics at the Uniformed Services University of Health Sciences.
He currently serves as the Fort Bragg Site Principal investigator of two NIH-funded research studies to include Smallpox/Influenza Vaccination and Myopericardial Injury/Inflammation study and Molecular and Immunologic Analysis of Anthrax Vaccine Immune Responses in the context of Adverse Events. In addition, Dr. McClenathan was an NIH sub-grant recipient (2015) for metabolomics vaccine research.
Dr. McClenathan’s leadership roles have included being the Chief of Allergy and Immunology for Womack Army Medical Center at Fort Bragg, NC and Walter Reed National Military Medical Center in Bethesda, MD. Additionally, before his retirement from Active Duty, he served as the Chief, Department of Medicine for Womack Army Medical Center. He currently leads a regional site of the Defense Health Agency-Immunization Healthcare Branch at Fort Bragg, NC.
Dr. McClenathan’s awards and decorations include the Legion of Merit Medal, the Bronze Star Medal, the Meritorious Service Medal, the Joint Service Commendation Medal, the Commander’s Award for Civilian Service, and the Expert Field Medical Badge. He resides in Sanford, NC with his wife, Yvonne, and his son’s Michael and Brandon.

Career Highlights: Positions, Projects, Deployements, Awards and Additional Publications

Regional Medical Director, Defense Health Agency-Immunization Healthcare Branch 2013-present

Chief, Department of Medicine, Womack Army Medical Center, Fort Bragg, NC 2013

Chief, Allergy/Immunology/Immunizations Service, Walter Reed National Military Medical Center, Bethesda, MD 2012-2013

Staff Allergist , Allergy/Immunology/Immunizations Service, Walter Reed National Military Medical Center, Bethesda, MD 2011-2012

Chief, Allergy and Clinical Immunology Service, Womack Army Medical Center, Fort Bragg, NC 2005-2011

Allergy and Clinical Immunology Fellow, Walter Reed Army Medical Center, Washington DC 2003-2005

Chief of Medical Residents and Internal Medicine Staff, Tripler Army Medical Center, Honolulu, HI 2002-2003

Medical Resident, Department of Medicine, Tripler Army Medical Center, Honolulu, HI 200-2002

Representative Bibliography

McClenathan BM, Torrington KG, Uyehara C. “Family Member Presence During Cardiopulmonary Resuscitation: A Survey of U.S. and International Critical Care Professionals.” Chest 2002; 122: 2204-2211.

McClenathan BM, Torrington KG, Uyehara C. Letter to the editor, Chest; 2003, 124:769

Martin CR, Haymore B, Nelson M, McClenathan B, Johnson J, Engler RJM. “Cutaneous Reactivity to Smallpox Vaccine: Gender and Product Differences.” JACI 2009; 123: S163

Wolverton WO, McClenathan BM. Prolonged Hypogammaglobulinemia after adjuvant rituximab for Hodgkin’s lymphoma presenting with refractory urticaria.” Annals of Allergy, Asthma and Immunology. 2012; 109: 473-474.

Engler RJM, Nelson MR, Collins Jr. LC, Spooner C, Hemann BA, Gibbs BT, Atwood JE, Howard RS, Chang AS, Cruser DL, Gates DG, Vernalis MN, Lengkeek MS,

Bruce M. McClenathan, MD, Delisha A. Stewart, PhD, Christina E. Spooner, MS Wimal W. Pathmasiri, PhD, Jason P. Burgess, PhD, Susan L. McRitchie, MS, Young S. Choi, MD, Susan C.J. Sumner, PhD. Metabolites as Biomarkers of Adverse Reactions Following Vaccination: A Pilot Study using Nuclear Magnetic Resonance Metabolomics